This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
4lly
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| + | |||
==Crystal structure of Pertuzumab Clambda Fab with variable and constant domain redesigns (VRD2 and CRD2) at 1.6A== | ==Crystal structure of Pertuzumab Clambda Fab with variable and constant domain redesigns (VRD2 and CRD2) at 1.6A== | ||
<StructureSection load='4lly' size='340' side='right' caption='[[4lly]], [[Resolution|resolution]] 1.60Å' scene=''> | <StructureSection load='4lly' size='340' side='right' caption='[[4lly]], [[Resolution|resolution]] 1.60Å' scene=''> | ||
| Line 5: | Line 6: | ||
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene></td></tr> | ||
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4llu|4llu]], [[4llq|4llq]], [[4llw|4llw]], [[4llm|4llm]], [[4lld|4lld]]</td></tr> | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4llu|4llu]], [[4llq|4llq]], [[4llw|4llw]], [[4llm|4llm]], [[4lld|4lld]]</td></tr> | ||
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4lly FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4lly OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4lly RCSB], [http://www.ebi.ac.uk/pdbsum/4lly PDBsum]</span></td></tr> | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4lly FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4lly OCA], [http://pdbe.org/4lly PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4lly RCSB], [http://www.ebi.ac.uk/pdbsum/4lly PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4lly ProSAT]</span></td></tr> |
</table> | </table> | ||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
| Line 15: | Line 16: | ||
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
</div> | </div> | ||
| + | <div class="pdbe-citations 4lly" style="background-color:#fffaf0;"></div> | ||
== References == | == References == | ||
<references/> | <references/> | ||
Revision as of 19:21, 11 August 2016
Crystal structure of Pertuzumab Clambda Fab with variable and constant domain redesigns (VRD2 and CRD2) at 1.6A
| |||||||||||
Categories: Human | Atwell, S | Chamberlain, A K | Demarest, S J | Guntas, G | Hansen-Estruch, C | Ho, C | Huang, F | Kuhlman, B | Leaver-Fay, A | Lewis, S M | Pustilnik, A | Sereno, A | Smith, E M | Truhlar, S M | Wu, X | Fab | Immune system
